Otros idiomas MeiraGTx Holdings plc

Acciones

MGTX

KYG596651029

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 01/05/2024			Varia. Cinco días.	Varia. 1 de enero.
4,99 ^USD	+2,25 %		+1,22 %	-28,92 %

16/04	MeiraGTx Holdings plc nombra a la Dra. Debra Yu para formar parte de cada uno de los Comités de Compensación y de Ciencia y Tecnología de la Junta Directiva	CI
14/03	MeiraGTx Holdings plc informa de los resultados de ganancias para el año completo finalizado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

MeiraGTx to Participate in Upcoming Investor Conferences	24/04
MeiraGTx Announces Oral Presentation at the 2024 American Academy of Oral Medicine (AAOM) Annual Conference	18/04
MeiraGTx Holdings plc Appoints Dr. Debra Yu to Serve on Each of the Compensation Committee and Science and Technology Committee of the Board	16/04
MeiraGTx Reports Fourth Quarter and Full Year 2023 Financial and Operational Results and Recent Business Updates	14/03
MeiraGTx Holdings plc Reports Earnings Results for the Full Year Ended December 31, 2023	14/03
North American Morning Briefing : Inflation Data -2-	12/03
Who are OpenAI's new board members?	11/03
MeiraGTx to Receive $50 Million Milestone Payment from J&J's Janssen Under Bota-Vec Deal	13/02
MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals	13/02
MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals	13/02
Progress In Preventing Blindness	26/01
Enavate Sciences Backs Graviton Bioscience in Financing Round to Advance Development of Selective ROCK2 Inhibitors	03/01
MeiraGTx sells XLRP gene therapy to Janssen	22/12
Sector Update: Health Care Stocks Rise in Late Afternoon Trading	21/12
Sector Update: Health Care Stocks Advance in Afternoon Trading	21/12
MeiraGTx Holdings Shares Rise on Sale of Remaining Bota-vec Interests to Janssen Pharmaceuticals for Up to $415 Million	21/12
MeiraGTx Announces Asset Purchase Agreement Involving its AAV-RPGR Collaboration for up to $415 million	21/12
Janssen Pharmaceuticals, Inc. agreed to acquire Assets of MeiraGTx Holdings plc from MeiraGTx Holdings plc for approximately $130 million.	21/12
MeiraGTx to Participate in Upcoming Investor Conferences	21/11
MeiraGTx Announces Third Quarter 2023 Financial and Operational Results	14/11

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas MeiraGTx Holdings plc

Acciones

MGTX

KYG596651029

Otros idiomas

Filtros